Bladder Tumour - MD Browse

Bladder Tumour

Speciality
Spotlight

Clinical Pharmacology

Bladder
Tumour

M.C.Hayes, B.R. Birch, A.J. Cooper and J.N. Primrose [ Departments of Urology and University Department of Surgery, Southampton General Hospital, Southampton, UK]

Cellular Resistance to Mitomycin C is Associated with Overexpression of MDR-1 in a Urothelial Cancer Cell Line [ MGH-U1]

BJU International, volume 87, Number 3, February 2001, Pg.Nos. 245-250

Conclusion – Urothelial cancer cell resistance to mitomycin C is associated with cross resistance to epirubicin and overexpression of MDR-1, suggesting that mitomycin C falls within the MDR category. Clinical application of this methodology may allow patients to be identified who are unlikely to benefit from intravesical chemotherapy

Speciality Spotlight

Clinical Pharmacology

Bladder Tumour

M.C.Hayes, B.R. Birch, A.J. Cooper and J.N. Primrose [ Departments of Urology and University Department of Surgery, Southampton General Hospital, Southampton, UK]
Cellular Resistance to Mitomycin C is Associated with Overexpression of MDR-1 in a Urothelial Cancer Cell Line [ MGH-U1]
BJU International, volume 87, Number 3, February 2001, Pg.Nos. 245-250

Conclusion – Urothelial cancer cell resistance to mitomycin C is associated with cross resistance to epirubicin and overexpression of MDR-1, suggesting that mitomycin C falls within the MDR category. Clinical application of this methodology may allow patients to be identified who are unlikely to benefit from intravesical chemotherapy

By Oleg Iuchis|2022-07-20T16:44:00+00:00July 20, 2022|Uncategorized|Comments Off

About the Author: Oleg Iuchis

It is a long established fact that the read will been distracted by there readable an important content. It is a long established fact that the read will been distracted.

It is a long established fact that the read will been distracted by there readable an important content. It is a long established fact that the read will been distracted.